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Abstract 
Two weak bases, PG-300995 (anti-HIV agent) and NSC-639829 (anti-tumor agent), whose log S – pH 
profiles had been previously published, but whose pKa values had not been reported, were analyzed 
using a method which can determine pKa values from log S – pH data. This “SpH-pKa” technique, 
although often practiced, can result in inaccurate pKa values, for a variety of reasons. The operational 
SpH-pKa values were compared to those predicted by MarvinSketch (ChemAxon), ADMET Predictor 
(Simulation Plus), and ACD/Percepta (ACD/Labs). The agreement for the sparingly-soluble PG-300995 
was reasonably good. However, a substantial difference was found for the practically-insoluble NSC-
639829. To probe this further, the pKa of NSC-639829 was measured by an independent 
spectrophotometric cosolvent technique. The log S - pH profile of NSC-639829 was then re-analyzed 
with the independently-measured pKa. It was found that the equilibrium model which best fit the 
solubility data is consistent with the presence of a monocationic NSC-639829 dimeric species below pH 
4. This illustrates that an independently-determined accurate pKa is critical to mechanistic 
interpretations of solubility-pH data. Apparently, the Henderson-Hasselbalch equation holds for PG-
300995, but not NSC-639829.  
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Introduction 
It is possible to determine the ionization constant (pKa) of an ionizable molecule from its solubility-
pH profile (log S - pH), provided the curve is accurately predicted by the well-known Henderson-
Hasselbalch equation [1] (cf., Appendix). This simple pKa-from-solubility (SpH-pKa) method has been 
popularized by Zimmermann [2], and has been practiced often, as noted in the critical pKa compilations 
by Prankerd [3].  However, the SpH-pKa method can be significantly inaccurate when sample molecules 
in saturated solutions react with buffer components to form water-soluble complexes, or with each 
other to form water-soluble aggregates/oligomers (dimers, trimers, … [4]) or micelles with large 
aggregation numbers [5]. Ionizable molecules that are surface-active (e.g., long-chain acylcarnitines [5], 
prostaglandins [6]) or that have strong acid-base hydrogen potentials (e.g., oxytetracycline [7], 
cefadroxyl [8]) have a tendency to form self-aggregates and/or micelles in saturated aqueous solutions 
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[9,10], especially under the high concentrations used to characterize drug-salt precipitates [11,12]. 
These complications are not taken into account in SpH-pKa determinations.  
Reliable and widely-available pKa methods have been developed over the last two decades to 
measure the pKa of practically-insoluble molecules, under conditions where saturation is avoided and 
self-aggregation is minimized [13,14]. Potentiometric and UV methods are particularly well-suited for 
measuring pKa values. The Yasuda-Shedlovsky [15] and Origin-Shifted Yasuda-Shedlovsky [9] methods 
employing cosolvents have been amply demonstrated to determine accurate pKas of molecules, some 
with solubility as low as 2 pg/mL (amiodarone[11,12]).  
In this study we considered two weak bases (Fig. 1), PG-300995 (anti-HIV agent) and NSC-639829 
(anti-tumor agent), whose log S – pH profiles have been published by Ran et al. [16] and Jain et al. [17], 
respectively.  
     
 
Figure 1. Structures of the molecules considered. 
In these cases, the pKa values of the molecules had not been reported. The undistorted shapes [9] of 
the two log S-pH profiles suggested that the simple weak-base Henderson-Hasselbalch equation could 
be used to describe the solubility-pH relationship. The data were first analyzed by the SpH-pKa method, 
using the computer program pDISOL-X (in-ADME Research) [10,12,18]. These operational pKa values 
were compared to those predicted using MarvinSketch (ChemAxon), ADMET Predictor (Simulation 
Plus), and ACD/Percepta (ACD/Labs). With PG-300995 (intrinsic solubility, S0 = 51 μg/mL [16]), the 
agreement was reasonably good with two of the three prediction programs. However, with the 
practically-insoluble NSC-639829 (S0 ≈ 30 ng/mL [17]), there was a substantial differences between the 
prediction and the value determined by the SpH-pKa method. To address the apparent inconsistency, it 
was decided to measure the pKa of NSC-639829 using dedicated instrumentation which can determine 
pKa values to high precision. Using the measured pKa, the log S - pH profile of NSC-639829 was 
rationalized with a monocationic dimeric species, predominating below pH 4.  (We could not obtain 
samples of PG-300995 to do the experimental pKa determination.) 
Experimental  
Materials 
NSC-639829 (>99 % purity) was synthesized by the National Cancer Institute and was used 
as received in the Jain et al. [17] study. In the Ran et al. [16] study, PG-300995 was a gift from 
Proctor and Gamble. Methanol was purchased from Sigma-Aldrich, St. Louis, MO, USA. Solutions 
and solvent mixtures were made with distilled water purchased from EMD Millipore, Billerica, 
MA, USA. Analytical grade potassium hydrogen phthalate and KCl were purchased from Acros 
Organics, New Jersey, USA. The ionic strength of water was adjusted to 0.15 M with KCl. The 
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base titrant was prepared by diluting CO2-free KOH concentrate (Fluka Analytical, St. Louis, 
MO, USA) to 0.5 M. It was standardized by titration against potassium hydrogen phthalate. The 
acid titrant, standardized 0.5 M HCl, was purchased from Sigma-Aldrich St. Louis, MO, USA. 
Legacy Solubility Data 
The Ran et al. [16] and Jain et al. [17] shake-flask solubility protocols were very similar. Briefly, 
excess solid was added to 1-2 mL of buffer solution. Enough NaCl had been added to the buffers to 
produce a total ionic strength, I = 0.2 M. The suspensions were agitated mildly for 5 d at 23 °C for NSC-
639829 and 7-10 d at 25 °C for PG-300995. At the end of the stirring period, pH was read, after which 
the solutions were filtered and the concentrations were determined by HPLC. Mostly 10 mM buffers 
were used: glycine/HCl for pH < 3, citrate for pH 3-5, phosphate for pH 5-8, and glycine/NaOH for pH > 
8.  
The data used in this study were digitized from the log S – pH plots in the original publications (11 
and 13 pH points for PG-300995 and NSC-639829, respectively).  
Spectroscopic Measurement of the pKa of NSC-639829 
The pKa was determined at 25 ± 0.1 °C using the SiriusT3 UV spectroscopic (UV-metric) method. The 
sample was added to a SiriusT3 vial as 5 microliters of 10 mM DMSO stock solution and was initially 
titrated in a Fast-UV pKa screening assay. The sample was titrated from pH 2 - 12 at concentrations of 32 
- 16 µM under methanol-water co-solvent conditions. Only one pKa, with a value of 3.7, was observed. 
Consequently, 5 microliters of a 10 mM DMSO stock solution of NSC-639829 were dispensed into a 
SiriusT3 vial and the sample was titrated in a triple titration from pH 1.5 - 5.0 at concentrations of 29 - 
14 µM in three different ratios of methanol-water cosolvent. The average methanol concentration was 
40.9, 30.2 and 21.6 % w/w in the first, second and third titrations, respectively. The presence of 
cosolvent caused the pKa to shift from its aqueous value. The apparent pKa in the presence of cosolvent 
is referred to as the psKa. Multi-wavelength UV spectra (200 - 750 nm) and pH data were collected every 
0.2 pH units throughout each titration. The SiriusT3 Refine software used target factor analysis (TFA) to 
rationalize the 3D matrix of absorbance vs wavelength vs pH. The psKa values for each titration were 
determined as the point at which the rate of UV absorbance change was greatest across the selected 
wavelength range as a function of pH. The aqueous pKa was determined by Yasuda-Shedlovsky 
extrapolation of the psKa values from each titration. There was no evidence of significant sample 
impurities in the pKa determination. 
Predicted pKa 
Values of pKa were predicted using MarvinSketch
TM 5.3.7 (ChemAxon Ltd., Budapest, Hungary; 
www.chemaxon.com), and corroborated with ADMET PredictorTM 7.0 (Simulation Plus, Inc., Lancaster, 
CA, USA; www.simulations-plus.com), and ACD/PerceptaTM 14 (ACD/Labs, Toronto, Canada; 
www.acdlabs.com). The predictions were used as a guide for some of the SpH-pKa analysis.   
Refinement of Intrinsic Solubility, Aggregation Constants, and SpH-pKa  
Detail of the mathematical approach in the pDISOL-X (in-ADME Research) computer program has 
been described by Völgyi et al. [18]. Briefly, the data analysis method uses measured log S - pH, along 
with standard deviations, SD (log S), as input into the pDISOL-X program. An algorithm was developed 
which considers the contribution of all species proposed to be present in solution, including all buffer 
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components (e.g., citrate, phosphate, glycine). The approach does not depend on any explicitly derived 
extensions of the Henderson-Hasselbalch equations. The computational algorithm derives its own 
implicit equations internally, given any practical number of equilibria and estimated constants, which 
are subsequently refined by weighted nonlinear least-squares regression [9,18]. Therefore, in principal, 
drug-salt precipitates, -aggregates, -complexes, - bile salts, -surfactant can be accommodated [4,9,18]. 
Presence of specific buffer-drug species can be tested. The program assumes an initial condition for the 
suspension of the solid drug in the buffer solution, ideally with the compound remaining saturated over 
a wide range of pH. First, the program calculates the volume of acid titrant that would lower the pH of 
the suspension to ~0. From there, a sequence of perturbations with standardized NaOH is simulated, 
and solubility calculated at each point (in pH steps of 0.005-0.2), until pH ~ 13 is reached. The ionic 
strength is rigorously calculated at each step, and pKa values (as well as solubility products, aggregation 
and complexation constants) are accordingly adjusted [9]. Also, the pH electrode parameters are 
adjusted for the changing ionic strength [9]. 
At the end of the pH-speciation simulation, the calculated log S vs. pH curve is compared to 
measured log S vs. pH. A log S-weighted nonlinear least squares refinement commences to refine the 
proposed equilibrium model, using analytical expressions for the differential equations. The process is 
repeated until the differences between calculated and measured log S values reach a stable minimum, 
as described elsewhere in detail [9,18]. 
Results and Discussion 
The aqueous pKa value was determined by Yasuda-Shedlovsky extrapolation to be 3.76 ± 0.03. Figure 
2a shows the Yasuda-Shedlovsky plot of psKa + log [H2O] vs. 1000/dielectric constant. The spectra 
measured during titration in 40.9 % methanol are shown in Figure 2b. Each line represents a spectrum 










Figure 2. (a) Yasuda-Shedlovsky extrapolation of psKa (+ log [H2O]) at three ratios of methanol to water. 
Aqueous pKa determined from intercept with vertical red line, equivalent to 1000/dielectric constant for 
water, minus the log [H2O]. (b) Spectra measured during titration in 40.9% methanol. Each line represents 
spectrum measured at a different pH between 1.5 and 5.2. 
The pKa results and those of the re-analysis the Ran et al. [16] and Jain et al. [17] solubility-pH data 
are summarized in Table 1.  
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 Table 1. Summary of the Results of the Re-Analysis of the PG-300995 [16] and NSC-639829 [17] Data. 
 
a
pKa values predicted by MarvinSketch (ChemAxon). Underlined values refers to acidic group ionization; otherwise, the 
value is that of basic group ionization. 
b
Refined pKa by the SpH-pKa method. 
c
Measured pKa by UV cosolvent extrapolation 
from 21.6-40.9 % w/w CH3OH-H2O (this work). 
d
S0 = intrinsic solubility (this work). 
e





Acidic pKa not found experimentally below pH 12 in Fig.3b. Also, preliminary UV pKa assay from pH 2 – 12 
indicated no additional pKas within the range. 
 
PG-300995 pKa and S0 
The two MarvinSketch-predicted pKas for PG-300995 are 3.52 (benzimidazole –N= basic 
functionality) and 10.58 (–NH- acidic group). The corresponding amine pKa from ADMET Predictor 
(average over 2 tautomers) was 3.60, in close agreement with that of MarvinSketch. However, the 
value from ACD/Percepta, 5.30, was less concordant. The refined SpH-pKa is 3.61 ± 0.06, indicated by the 
pH in the bend in the log S - pH curve in Figure 3a, agrees very well with the predictions from two of the 
commercial programs. There is no indication of the acidic ionization in the solubility profile, suggesting 
that the second pKa must be greater than 9, which is consistent with the predicted value from all three 
pKa prediction programs. Since the molecule is relatively simple and not too insoluble, and since the 
predicted basic pKa agrees with the measured value, the refined SpH-pKa tentatively was taken to be a 
measure of the true pKa. Thus, the Henderson-Hasselbalch equation is thought to be a valid description 
of the solubility-pH curve.  This is, of course, a tentative assignment, since the independently measured 
value of the pKa of PG-300995 is not available. 
The refined intrinsic solubility, S0 = 51.3 ± 0.7 μg/mL, agrees well with the reported value [16]. Each 
point in Figure 3a was assigned the standard deviation of 0.1 (not reported in the original publication). 
The overall goodness-of-fit, GOF = 0.77, suggests that the points are scattered by 0.077 log units about 
the best-fit curve. 
NSC-639829 pKa 
The two MarvinSketch-predicted pKas for NSC-639829 were far from what was indicated in Figure 
3b. It is quite clear that there is no acidic ionization corresponding to the urea NH group below pH 12. 
This was also the finding of the spectrophotometric pKa determination. The dimethylaniline amine SpH-
pKa and the predicted value (Table 1) were different by 2.4 log units. With the adage “prediction guides 
but experiment decides,” it was decided to measure the pKa(s) of NSC-639829 by an independent 
method. One pKa was evident by the spectrophotometric method, and its value was different from both 
the predicted and the refined SpH-pKa values (Table 1).  In depth analyses of many log S – pH profiles [10, 
12, 18] show that pKa values determined by modern purpose-built pKa instrumentation [13, 14] can 
differ substantially from SpH-pKa values, suggesting that the simple Henderson-Hasselbalch equation 
may not always be an accurate predictor of the pH dependence of solubility. This is particularly evident 
in examples such as prostaglandin F2α [6]. We consequently pursued possible explanations for the 
difference between SpH-pKa = 4.70 ± 0.12 and the UV-measured pKa = 3.76 ± 0.03.  
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Figure 3. (a) solubility profiles of (a) PG-300995 and (b) NSC-639829. The diagonal region has slope of -1. The pH 
in the bend, between the slope -1 and slope 0 is the apparent pKa, which may or may not be the true pKa. 
 
A step-by-step solubility model construction was described recently by Avdeef [10]. Knowing the 
accurate pKa starts the process. The shape of the log S – pH curve is compared against a series of 
templates [4,9,10]. For the profile in Figure 3b, the key characteristics are: pKa
app > pKa and slope = -1 in 
the diagonal region, suggesting that a mixed-charge dimer (or higher order oligomer) needs to be 
considered (CASE 3b [4,9,10,12]). The log S0 can be estimated as the solubility in the pH >> pKa region of 
the curve. Three equilibria are needed to describe such a model: H++B ↔ BH+(pKa), B ↔ B(s) (1/S0), and 
BH++ B ↔ BHB+ (K2). Having initial estimates of constants corresponding to proposed equilibrium 
reactions, it is possible to refine the model by weighted nonlinear regression, a procedure described 
elsewhere [18]. The iterative refinement process continued to convergence. 
Figure 4 shows the refined results for NSC-639829. The solid (red) line is the best fit to the log S data 
at various pH values. The dashed line is calculated by the Henderson-Hasselbalch equation, 
incorporating the spectrophotometrically-measured pKa.  
 
 
Figure 4. Solubility profile of NSC-639829 incorporating the UV-determined pKa in the 
equilibrium model. The dashed line is calculated using the Henderson-Hasselbalch equation. 
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Figure 5 shows the distribution of various species as a function of pH. 
At pH = SpH-pKa (4.70) in a suspension containing 1 mg/mL added drug, the concentration of the free 
base, [B] = 5.79 x 10
-8
 M (= S0, the intrinsic solubility), accounts for 66 % of the total aqueous 
concentration of NSC-639829. At this pH, [BH
+
] accounts for 8 % of the total aqueous concentration of 
the drug, while [BHB
+
] accounts for the remaining 26 %. The molecule is 34 % ionized at this pH. 
At pH = pKa (3.76) in a 1 mg/mL suspension, the concentration of the free base remains the same, 
but it accounts for only 18 % of the total aqueous concentration of NSC-639829. At this pH, [BH+] also 
accounts for 18 % of the total ([B] = [BH+] when pH = pKa), while [BHB
+] accounts for the remaining 64 
%. The molecule is 82 % ionized at this pH.  




] = 3.4 is expected to remain unchanged as 
long as the solutions remain saturated (as suggested by the two thick diagonal lines of identical slope -1 
in Figure 5), provided there are no other unaccounted equilibria when the positively charged species 
become less concentrated than the uncharged free base (pH > 4.7).  
  
 
Figure 5. Speciation profile of NSC-639829. The thick solid lines correspond to the concentrations of the 
drug species. The thin lines correspond to the concentrations of the three buffer components used to 
simulate the data: glycine, phosphate, and citrate. The 1 mg/mL used in the simulation suggests that all 
of the solid dissolves when pH < 0.5. 
 
Conclusions 
   We re-analyzed the previously published solubility-pH data of two weak base drugs. It was 
tentatively proposed, based on the agreement between the apparent pKa (SpH-pKa) and that predicted 
by MarvinSketch and ADMET Predictor (but not ACD/Percepta), that the solubility profile of the more 
soluble drug, PG-300995, could be adequately predicted by the Henderson-Hasselbalch (HH) equation. 
However, the practically-insoluble NSC-639829 drug could not be predicted by the simple HH equation. 
Its pKa was determined here. The inclusion of the independently-measured pKa in the equilibrium model 
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suggested that the “anomalous” profile of NSC-639829 can be explained by presence of a mixed-charge 
cationic dimer (BHB
+
).  This illustrates that an independently-determined accurate pKa is critical to 
interpreting solubility-pH data of ionizable compounds. However, predicted pKa values can be very 
helpful guides in the initial stages of such investigations. Apparently, the simple Henderson-Hasselbalch 
equation holds for PG-300995, but not NSC-639829.  
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Appendix – Derivation of the Solubility - pH Equations 








]        (A1) 
  B(s)  B   S0 = [B]           (A2) 
Solubility, S, at a particular pH is defined as the mass balance sum of the concentrations of all of the 
species dissolved in the aqueous phase: 
  S = [B] + [BH+]                      (A3) 
where the square brackets denote molar concentration of species. The above equation can be 
transformed into an expression containing only constants and [H
+
] (as the only variable), by substituting 
the ionization and solubility Eqs. (A1) and (A2) into Eq. (A3). 
  log S = log ( [B] + [H+][B] /Ka ) 
    = log [B] + log ( 1 + [H+] / Ka )      
     = log S0 + log ( 1 + 10 
+pKa – pH)                    (A4) 
Eq. (A4) is usually called the Henderson-Hasselbalch equation for a monoprotic weak base, and 
describes a hyperbolic-shaped log S – pH curve. At the bend in the log S – pH curve, the pH equals the 
pKa.  
It can be hypothesized that the dimeric mixed-charge weak base species, (B.BH+), also forms, which 
contains a 1:1 ratio of B and BH
+
. An additional equilibrium equation needs to be added to the mass 
balance. 
 B + BH+    (B.BH+)   K2 = [B.BH
+] / [B][BH+]               (A5) 
Eq. (A3) needs to be expanded accordingly. 
  S = [B] + [BH
+
] + 2 [B.BH
+
]                     (A6) 
In logarithmic form, 
  log S = log ( [B] + [H+][B] /Ka + 2 K2[B][BH
+]) 
        = log ( [B] + [H+][B] /Ka + 2 K2[B]
2 [H+] /Ka ) 
       = log S0 + log ( 1 + { 1+2 K2 S0 } 10 
+pKa – pH )                   (A7) 
For NSC-639829, the factor in the braces in Eq. (A7) equals 8.60 (=1 + 2 x 10+7.80 x 10-7.22). When the 
logarithm of the factor (0.94) is taken into the exponent, the resulting equation appears to equal Eq. 
(A4), except that the pKa is replaced with the SpH-pKa value (3.76+0.94 = 4.70). The hypothesized 
presence of the mixed-charge dimer appears to shift the original Henderson-Hasselbalch equation in 
the positive pH direction by nearly a log unit. The presence of self-aggregated species of other 
stoichiometries can distort the shape of the simple Henderson-Hasselbalch equation in a number of 
different ways [4,9,10,12,18]. The example in the present study is one of the simpler types of distortion. 
With increasing pH, it is possible for the protonated dimer, B.BH+, to lose the ionizable proton to 
become the water-soluble neutral-species dimer, B2.  The pKa for such a process would not be expected 
to be exactly the same as the measured pKa. For example, ketoprofen bound to sodium taurocholate 
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micelles shows such a secondary pKa [9]. There was no hint of such a process in the case of NSC-639829, 
but a more thorough investigation would require additional log S-pH measurements with total 




©2015 by the authors; licensee IAPC, Zagreb, Croatia. This article is an open-access article distributed under the terms and 
conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/)  
